子宫操纵器对子宫内膜癌复发和死亡率的影响:意大利妇科内镜学会的多中心研究
该多中心研究纳入7个意大利中心951例子宫内膜癌腹腔镜分期手术患者,其中579例使用子宫操纵器、372例未使用。中位随访46个月后,使用组与未使用组的复发率分别为13.5%和11.6%(P=.37),单因素和多因素分析均显示子宫操纵器使用与复发风险无关,无病生存、疾病特异性生存和总生存及复发部位在两组间相似。
要点
- 使用子宫操纵器组复发率13.5%,未使用组11.6%,差异无统计学意义(P=.37)。
- 单因素分析子宫操纵器使用与复发风险无关(OR 1.18,95%CI 0.80-1.77),多因素分析同样无关(OR 1.00,95%CI 0.60-1.70)。
- 子宫操纵器类型及尖端是否有球囊与复发风险无显著关联,无病生存、疾病特异性生存和总生存两组相似。
核心结论
- 腹腔镜手术中使用子宫操纵器不影响子宫内膜癌患者的复发风险,对疾病特异性生存、总生存及复发部位亦无影响。
研究设计与样本
- 回顾性多中心研究,纳入7个意大利中心连续接受腹腔镜子宫内膜癌分期手术的患者951例,使用子宫操纵器组579例,未使用组372例。
- 采用多因素分析校正混杂因素,并使用倾向性评分匹配以减少选择偏倚。
主要发现
- 中位随访46个月(范围12-163个月),使用子宫操纵器组复发率13.5%,未使用组11.6%(P=.37)。
- 单因素分析子宫操纵器使用与复发风险的OR为1.18(95%CI 0.80-1.77),多因素分析OR为1.00(95%CI 0.60-1.70)。
- 淋巴结阳性及肌层浸润>50%与复发风险独立相关。
- 无病生存、疾病特异性生存和总生存两组相似,倾向性评分匹配分析证实上述结果。
- 复发部位两组可比,子宫操纵器类型及尖端是否有球囊与复发风险无显著关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although widely adopted, the use of a uterine manipulator during laparoscopic treatment of endometrial cancer represents a debated issue, and some authors hypothesize that it potentially may cause an increased risk of relapse, particularly at specific sites. OBJECTIVE: Our aim was to evaluate the risk and site of disease recurrence, overall survival, and disease-specific survival in women who had laparoscopic surgery with and without the use of a uterine manipulator. STUDY DESIGN: Data were reviewed from consecutive patients who had laparoscopic surgery for endometrial cancer staging in 7 Italian centers. Subjects were stratified according to whether a uterine manipulator was used during surgery; if so, the type of manipulator was identified. Multivariable analysis to correct for possible confounders and propensity score that matched the minimize selection bias were utilized. The primary outcome was the risk of disease recurrence. Secondary outcomes were disease-specific and overall survival and the site of recurrence, according to the use or no use of the uterine manipulator and to the different types of manipulators used. RESULTS: We included 951 patients: 579 patients in the manipulator group and 372 patients in the no manipulator group. After a median follow-up period of 46 months (range,12-163 months), the rate of recurrence was 13.5% and 11.6% in the manipulator and no manipulator groups, respectively (P=.37). Positive lymph nodes and myometrial invasion of >50% were associated independently with the risk of recurrence after adjustment for possible confounders. The use of a uterine manipulator did not affect the risk of recurrence, both at univariate (odds ratio, 1.18; 95% confidence interval, 0.80-1.77) and multivariable analysis (odds ratio, 1.00; 95% confidence interval, 0.60-1.70). Disease-free, disease-specific, and overall survivals were similar between groups. Propensity-matched analysis confirmed these findings. The site of recurrence was comparable between groups. In addition, the type of uterine manipulator and the presence or not of a balloon at the tip of the device were not associated significantly with the risk of recurrence. CONCLUSION: The use of a uterine manipulator during laparoscopic surgery does not affect the risk of recurrence and has no impact on disease-specific or overall survival and on the site of recurrence in women affected by endometrial cancer.
引用
- Uccella S, Bonzini M, Malzoni M, et al. The effect of a uterine manipulator on the recurrence and mortality of endometrial cancer: a multi-centric study by the Italian Society of Gynecological Endoscopy. Am J Obstet Gynecol. 2017. PMID: 28147240. doi:10.1016/j.ajog.2017.01.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。